The Drug Enforcement Agency recently released its much-anticipated Interim Final Rule (IFR) on electronic prescribing of controlled substances. While additional clarification is needed from DEA, the rule opens the door for electronic transmission of controlled-substance prescriptions to pharmacies and removes a significant barrier to the overall use of electronic prescribing.
From activating state insurance exchanges to setting up accountable care organizations, the success of health reform will depend on smart IT engineering.